शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
MAXHEALTHNSEMAX HEALTHCARE INS LTD· Healthcare ServicesHighPositive
Announced Thu, 13 Aug, 2026 · 14:33 IST

Max Healthcare Q1 FY27: Revenue up 16% at Rs 2,982 Cr, PAT Rs 357 Cr

EBITDA margin compressionRelated-party transactionsResults View source PDFExplain this filing

MAXHEALTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.6%Reaction day
₹1006.80
prior close
₹999.80
announcement price
In-mkt
timing
Nifty 100market-0.1%+0.7% vs market
Hospital peers, median of 24sector-0.7%+1.3% vs sector

On the reaction day the stock moved 0.7 pts more than Nifty 100 and 1.3 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+3.1
10m
+3.1
15m
+2.3
30m
+0.9
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.6-0.1+0.7-0.7+1.3
Next day
+0.2-0.3+0.5-0.9+1.1
2d
-0.3-0.6+0.3-1.2+0.9
3d
+0.8-1.0+1.8-1.3+2.0
4d
-1.0-1.4+0.4-1.6+0.7
5d
-0.9-0.8-0.1-1.3+0.4
1w
-1.6-0.9-0.7-1.2-0.4
15d
-1.4-2.3+0.9-2.0+0.6
1m
+2.3-5.5+7.8-1.6+3.9
2m
-14.4-7.2-7.2-11.7-2.7
3m
—————
UpDownMarket · Nifty 100Sector · Hospital peers, median of 24Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Max Healthcare Q1 FY27: Gross revenue Rs 2,982 Cr, up 16% YoY, driven by 10% rise in occupied bed days. Operating EBITDA Rs 704 Cr, up 15% YoY, but margin slipped to 24.8% from 24.9% and 26.8% in Q4 FY26. PAT Rs 357 Cr, up 3% YoY. Operational bed capacity rose to 5,379 with occupancy at 75%. Completed Kalinga Hospital and YPPL acquisitions, adding around 700 beds. Net debt rose to Rs 2,384 Cr from Rs 1,908 Cr. Board approved Rs 425 Cr capex for Vaishali tower and foray into medical education.

Likely market impact

Revenue and EBITDA growth in line with expectations. Slight margin dip due to new capacity. Acquisitions and capex signal growth push but raise net debt.